← Eichor
Condition: Cholangiocarcinoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cholangiocarcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
Phase N/A · 1 location(s) · City of Hope Medical Center · NCT07224750Lenvatinib Plus Sintilimab in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Liver Cancer
Phase 2 · 1 location(s) · Fudan University · NCT05010681Study on Sequential Cryoablation, Relaforp Alpha, and Chemotherapy for Bile Duct Tumors
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07726446A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Meth
Phase N/A · 1 location(s) · Centro di Riferimento Oncologico - Aviano · NCT06028724SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
Phase 1 · 5 location(s) · Verismo Therapeutics · NCT05568680Efficacy and Safety of Postoperative Concurrent Chemoradiotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Ca
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07636824Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabili
Phase 2 · 1 location(s) · AHS Cancer Control Alberta · NCT05451043Trop2-targeted immunoPET Imaging of Solid Tumors
Phase 2/Phase 3 · 1 location(s) · RenJi Hospital · NCT06851663Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based o
Phase N/A · 1 location(s) · Zhongda Hospital · NCT06849180Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Meta
Phase 1/Phase 2 · 38 location(s) · Institut de Recherches Internationales Servier · NCT06501625Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients
Phase N/A · 1 location(s) · Mayo Clinic · NCT04753996Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer
Phase 2 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT06280508Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
Phase N/A · 1 location(s) · Mohamed Abdel-Rahman · NCT04792463PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma
Phase 2 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT05430698Perioperative Treatment of Resectable Intrahepatic Cholangiocarcinoma With the Combination of Adebrelimab and Apatinib a
Phase 2 · 1 location(s) · Lei ZHAO · NCT06296563Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE)
Phase N/A · 2 location(s) · Peking University Third Hospital · NCT06277531Targeted Navigation in Hepatocellular Carcinoma (HCC)
NA · 1 location(s) · University of Miami · NCT06260943In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Techno
Phase N/A · 1 location(s) · University of Nottingham · NCT07206355Intraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for Extrahepatic Cholangiocarcinoma
NA · 1 location(s) · National Cancer Center, Korea · NCT06168292Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma
Phase N/A · 1 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT06986486Collection of Blood and Tissue Samples From Patients With Primary Liver Cancer.
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT06899854A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcin
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07063888The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer
Phase N/A · 1 location(s) · Samsung Medical Center · NCT03637569A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers
Phase N/A · 40 location(s) · Federation Francophone de Cancerologie Digestive · NCT06541652LIver Transplantation for Non-Resectable Intrahepatic CholAngiocarcinoma (LIRICA)
NA · 1 location(s) · Azienda Sanitaria Ospedaliera · NCT06098547A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects W
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05849480A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable I
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05967182HYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patients With Adv
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06858735Agnostic Therapy in Rare Solid Tumors
Phase 2 · 8 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06638931DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liv
Phase N/A · 31 location(s) · Maastricht University Medical Center · NCT07717437
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.